Recombinant versus Urinary Follicle-Stimulating Hormone in the Low-Dose Regimen in Anovulatory Patients with Polycystic Ovary Syndrome: A Safer and More Effective Treatment

Background: We studied polycystic ovarian syndrome (PCOS) in fifty 25- to 37-year-old women who failed to conceive with clomiphene citrate treatment. Methods: Twenty patients were submitted to treatment with low-dose (75 IU) urinary FSH (uFSH) in order to achieve ovulation and 30 patients were treat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hormone research 2001-01, Vol.55 (5), p.224-228
Hauptverfasser:	Fulghesu, Anna Maria, Apa, Rosanna, Belosi, Chiara, Ciampelli, Mario, Selvaggi Jr, Luigi, Cucinelli, Francesco, Caruso, Alessandro, Mancuso, Salvatore, Lanzone, Antonio
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anovulation - drug therapy Anovulation - etiology Anovulation - physiopathology Dose-Response Relationship, Drug Estradiol - blood Female Follicle Stimulating Hormone - administration & dosage Follicle Stimulating Hormone - adverse effects Follicle Stimulating Hormone - isolation & purification Follicle Stimulating Hormone - therapeutic use Humans Original Paper Ovarian Hyperstimulation Syndrome - chemically induced Ovulation Ovulation Induction - methods Polycystic Ovary Syndrome - complications Recombinant Proteins Safety Urine - chemistry
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!